Posted Jun. 27, 2013 at 3:14 p.m.

Premium Lock Oxygen Biotherapeutics loses $10.3M in fiscal 2013

Published: 2013-06-27 15:14:53
Updated: 2013-06-27 15:14:53

Oxygen Biotherapeutics Oxygen Biotherapeutics

Oxygen Biotherapeutics (NASDAQ: OXBT) reported a net loss of $10.3 million in the company’s fiscal year 2013 ending April 30, a year that saw the the company take a number of steps to keep its financial footing as it focused its efforts on its lead drug candidate, a potential traumatic brain injury treatment....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders